J

Jennifer J. Hofmann

Haverford College

Publishes on Angiogenesis and VEGF in Cancer, Developmental Biology and Gene Regulation, Cell Adhesion Molecules Research. 30 papers and 5k citations.

30Publications
5kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

VE‐cadherin‐CreER <sup>T2</sup> transgenic mouse: A model for inducible recombination in the endothelium
Arnaud Monvoisin, Jackelyn A. Alva, Jennifer J. Hofmann et al.|Developmental Dynamics|2006
Cited by 254

To introduce temporal control in genetic experiments targeting the endothelium, we established a mouse line expressing tamoxifen-inducible Cre-recombinase (Cre-ERT2) under the regulation of the vascular endothelial cadherin promoter (VECad). Specificity and efficiency of Cre activity was documented by crossing VECad-Cre-ERT2 with the ROSA26R reporter mouse, in which a floxed-stop cassette has been placed upstream of the beta-galactosidase gene. We found that tamoxifen specifically induced widespread recombination in the endothelium of embryonic, neonatal, and adult tissues. Recombination was also documented in tumor-associated vascular beds and in postnatal angiogenesis assays. Furthermore, injection of tamoxifen in adult animals resulted in negligible excision (lower than 0.4%) in the hematopoietic lineage. The VECad-Cre-ERT2 mouse is likely to be a valuable tool to study the function of genes involved in vascular development, homeostasis, and in complex processes involving neoangiogenesis, such as tumor growth.